One Michigan man says he knew it had to be a scam when someone who claimed to be from Medicare reached out during the ...

Eli Lilly and Novo Nordisk are expected to announce deals with the White House to offer the lowest dose of their weight-loss ...

Health insurers are pulling out of the Medicare Advantage market. Discover which areas will gain or lose the most, and what ...

The one-year contract agreement resolves an impasse that could have blocked 33,000 patients from their health care providers.

Novo Nordisk, as well as Eli Lilly, would gain Medicare and Medicaid coverage for their blockbuster weight-loss drugs.

The lowest doses of Eli Lilly’s Zepbound and Novo Nordisk's Wegovy could be available for as little as $149 a month.

Obesity drugs have become an increasingly popular method of weight loss but most are not covered by insurance for that ...

As Medicare open enrollment begins, the Better Business Bureau (BBB) is warning consumers about pervasive scams that could ...

Tiffany Frink of HealthSpring breaks down 2026 Medicare Advantage highlights with Houston Life's Derrick Shore. Learn about ...

Referrals are home health providers’ “lifeblood” – but the referral landscape has become increasingly challenging, requiring ...

Starting next year, millions of Medicare patients will face new hurdles to access medical care through a program targeting ...